These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17386275

  • 21. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
    Mavrakanas N, Mendrinos E, Tabatabay C, Pournaras CJ.
    Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
    [No Abstract] [Full Text] [Related]

  • 22. [Intravitreal ranibizumab for age-related macular degeneration].
    Sørensen TL, Kemp H.
    Ugeskr Laeger; 2010 May 31; 172(22):1685-9. PubMed ID: 20525469
    [Abstract] [Full Text] [Related]

  • 23. Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration.
    Oubraham H, Cohen SY, Samimi S, Marotte D, Bouzaher I, Bonicel P, Fajnkuchen F, Tadayoni R.
    Retina; 2011 Jan 31; 31(1):26-30. PubMed ID: 20890246
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep 31; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 25. Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration.
    Mantel I, Zografos L, Ambresin A.
    Ophthalmologica; 2008 Sep 31; 222(5):321-3. PubMed ID: 18617755
    [Abstract] [Full Text] [Related]

  • 26. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C, Golbaz I, Stock G, Fous A, Kolar S, Pruente C, Schmidt-Erfurth U.
    Ophthalmology; 2008 Aug 31; 115(8):e39-46. PubMed ID: 18675694
    [Abstract] [Full Text] [Related]

  • 27. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy.
    Querques G, Bocco MC, Soubrane G, Souied EH.
    Acta Ophthalmol; 2008 Sep 31; 86(6):694-5. PubMed ID: 18752521
    [No Abstract] [Full Text] [Related]

  • 28. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M, Oddone F, Tedeschi M, Schiano Lomoriello D, Chiaravalloti A, Ripandelli G, Varano M.
    Retina; 2009 Mar 31; 29(3):329-34. PubMed ID: 19092732
    [Abstract] [Full Text] [Related]

  • 29. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.
    Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N.
    Am J Ophthalmol; 2008 Feb 31; 145(2):239-248. PubMed ID: 18222192
    [Abstract] [Full Text] [Related]

  • 30. [The first experience of intravitreal injection of Lucentis (ranibizumab) in the moist form of age-related maculodystrophy].
    Baĭborodov IaV.
    Vestn Oftalmol; 2009 Feb 31; 125(5):31-3. PubMed ID: 19916331
    [Abstract] [Full Text] [Related]

  • 31. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, Guiberteau B, Quentel G.
    Am J Ophthalmol; 2009 Sep 31; 148(3):409-13. PubMed ID: 19477713
    [Abstract] [Full Text] [Related]

  • 32. Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.
    Davis AS, Folk JC, Russell SR, Sohn EH, Boldt HC, Stone EM, Mahajan VB.
    Arch Ophthalmol; 2012 Aug 31; 130(8):1073-5. PubMed ID: 22893085
    [No Abstract] [Full Text] [Related]

  • 33. [Non-response and change of anti-VEGF agent in exsudative age-related macular degeneration].
    Manfreda I, Uhlig CE.
    Klin Monbl Augenheilkd; 2010 Aug 31; 227(8):657-8. PubMed ID: 20706974
    [No Abstract] [Full Text] [Related]

  • 34. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
    Carvounis PE, Kopel AC, Benz MS.
    Am J Ophthalmol; 2007 Mar 31; 143(3):504-5. PubMed ID: 17317395
    [Abstract] [Full Text] [Related]

  • 35. Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration.
    Framme C, Wolf S, Wolf-Schnurrbusch U.
    Invest Ophthalmol Vis Sci; 2010 Nov 31; 51(11):5965-9. PubMed ID: 20574019
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Bhatnagar P, Spaide RF, Takahashi BS, Peragallo JH, Freund KB, Klancnik JM, Cooney MJ, Slakter JS, Sorenson JA, Yannuzzi LA.
    Retina; 2007 Sep 31; 27(7):846-50. PubMed ID: 17891007
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function.
    Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2009 May 31; 50(5):2376-83. PubMed ID: 19136707
    [Abstract] [Full Text] [Related]

  • 39. Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment.
    Calvo-Gonzalez C, Reche-Frutos J, Donate J, Fernandez-Perez C, Garcia-Feijoo J.
    Am J Ophthalmol; 2011 Mar 31; 151(3):529-34. PubMed ID: 21236413
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.
    Holz FG, Amoaku W, Donate J, Guymer RH, Kellner U, Schlingemann RO, Weichselberger A, Staurenghi G, SUSTAIN Study Group.
    Ophthalmology; 2011 Apr 31; 118(4):663-71. PubMed ID: 21459217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.